Pricing Log in Create free account

Contineum Therapeutics, Inc. (CTNM) vs Rezolute, Inc. (RZLT)

Contineum Therapeutics, Inc. and Rezolute, Inc. are both Biotechnology companies. Contineum Therapeutics, Inc. and Rezolute, Inc. are of similar size ($352.1M and $345.9M). Across the 9 metrics below, Contineum Therapeutics, Inc. leads on 6 and Rezolute, Inc. on 3.

Valuation

Metric CTNM RZLT Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 1.47 3.97 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (18.76%) (19.74%) (32.88%)
Free cash flow yield (14.44%) (16.35%) (23.13%)

Profitability

Metric CTNM RZLT Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (29.80%) (59.04%) (51.96%)
Return on assets (28.34%) (53.82%) (46.06%)
Return on invested capital (4,845.62%) 0.00% 0.00%

Growth

Metric CTNM RZLT Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 0.46% 23.47% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CTNM RZLT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 31.11 9.68 4.97
Net debt to EBITDA 3.88 1.26 1.01

Dividend

Metric CTNM RZLT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CTNM RZLT Biotechnology median
Market cap 345.93m 352.10m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack